Federal officials approve use of Eli Lilly obesity drug Zepbound for treating sleep apnea December 22, 2024 by Washington Times The Food and Drug Administration on Friday approved the use of Eli Lilly medicine Zepbound, already prescribed for weight loss, as a treatment for sleep apnea in obese patients.